Anest. intenziv. Med. 2007;18(1):30-34

Incidence of postoperative residual curarization following cisatracurium and rocuronium-induced neuromuscular block: a prospective studyAnaesthesiology - Original Paper

M. Adamus, J. Koutná, D. Žáčková
Klinika anesteziologie a resuscitace, Fakultní nemocnice a Lékařská fakulta Univerzity Palackého, Olomouc

Objective:
To assess the incidence of postoperative residual curarization following cisatracurium and rocuronium-induced neuromuscular block.

Design:
Clinical, prospective, controlled study.


Setting:
Department of Anaesthesiology and Intensive Care Medicine, University Hospital,




Materials and methods:
We investigated residual curarization after general anaesthesia with either cisatracurium (CIS, n = 384) or rocuronium (ROC, n = 406) induced neuromuscular blockade without peroperative neuromuscular blockade monitoring in 790 patients. On admission to the recovery room we performed submaximal stimulation of the ulnar nerve (30 mA) and quantified the evoked muscle response with accelerometry (TOF-Watch® SX SX, Organon). The postoperative residual curarization was defined as TOF-ratio < 0.90, p < 0.05 was considered significant.

Results:
Postoperative residual curarization could be demonstrated in 24.5 % (CIS group) and 32.0 % (ROC group), respectively. Compared to the group with adequate neuromuscular recovery, the patients with residual blockade received a larger relaxant dose, were anaesthetised by a less experienced anaesthetist, a shorter time had elapsed since the last relaxant dose, their core temperature was lower and on average, they received less neostigmine at the end of anaesthesia (p < 0.05).

Conclusion:
The incidence of postoperative residual curarization remains a problem even following intermediate- acting neuromuscular blockers (cisatracurium, rocuronium). We suggest reversing the residual block after cisatracurium or rocuronium routinely, especially in the absence of perioperative neuromuscular monitoring.

Keywords: postoperative residual curarization; cisatracurium; rocuronium; TOF-ratio; postanaesthesia care unit

Published: February 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Adamus M, Koutná J, Žáčková D. Incidence of postoperative residual curarization following cisatracurium and rocuronium-induced neuromuscular block: a prospective study. Anest. intenziv. Med. 2007;18(1):30-34.
Download citation

References

  1. Viby-Mogensen, J. Postoperative residual curarization and evidence-based anaesthesia. Br. J. Anaesth., 2000, 84, p. 301-303. Go to original source... Go to PubMed...
  2. Herold, I. Svalová relaxancia v anesteziologii a intenzivní péči. 1. vydání. Praha : Maxdorf, 2004, p. 268. ISBN 80-7345-025-9.
  3. Cammu, G. Postoperative residual curarisation: complication or malpractice? Acta Anaesthesiol. Belg., 2004, 55, p. 245-249. Go to PubMed...
  4. Baillard, C., Clec', H. C., Catineau, J., Salhi, F., Gehan, G., Cupa, M., Samama, C. M. Postoperative residual neuromuscular block: a survey of management. Br. J. Anaesth., 2005, 95, p. 622-626. Go to original source... Go to PubMed...
  5. Cammu, G., De Witte, J., De Veylder, J., Byttebier, G., Vandeput, D., Foubert, L., Vandenbroucke, G., Deloof, T. Postoperative residual paralysis in outpatients versus inpatients. Anesth. Analg., 2006, 102, p. 426-429. Go to original source... Go to PubMed...
  6. Murphy, G. S. Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period. Minerva Anestesiol., 2006, 72, p. 97-109. Go to PubMed...
  7. Berg, H., Roed, J., Viby-Mogensen, J., Mortensen, C. R., Engbaek, J., Skovgaard, L. T., Kristel, J. J. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol. Scand., 1997, 41, p. 1095-1103. Go to original source... Go to PubMed...
  8. References and formulas used by the Body Surface Area Calculator. Formula for Body Mass Index. Formulas for Body Surface Area [on line]. [cit. 2006-10-20] Dostupné na WWW: http://www.halls.md/body-surface-area/refs.htm.
  9. Viby-Mogensen, J., Jorgensen, B. C., Ording, M. Residual curarization in the recovery room. Anesthesiology, 1979, 50, p. 539-541. Go to original source... Go to PubMed...
  10. Beemer, G. H., Rozental, P. Postoperative neuromuscular function. Anaesth. Intensive Care, 1986, 14, p. 41-45. Go to original source... Go to PubMed...
  11. Andersen, B. N., Madsen, J. V., Schurizek, B. A., Juhl, B. Residual curarization: a comparative study of atracurium and pancuronium. Acta Anaesthesiol. Scand., 1988, 32, p. 79-81. Go to original source... Go to PubMed...
  12. Bevan, D. R., Smith, C. E., Donati, F. Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium and pancuronium. Anesthesiology, 1988, 69, p. 272-276. Go to original source... Go to PubMed...
  13. Baillard, C., Gehan, G., Reboul-Marty, J., Larmignat, P., Samama, C. M., Cupa, M. Residual curarization in the recovery room after vecuronium. Br. J. Anaesth., 2000, 84, p. 394-395. Go to original source... Go to PubMed...
  14. McCaul, C., Tobin, E., Boylan, J. F., McShane, A. J. Atracurium is associated with postoperative residual curarization. Br. J. Anaesth., 2002, 89, p. 766-769. Go to original source... Go to PubMed...
  15. Eriksson, L. I., Lennmarken, C., Wyon, N., Johnoson, A. Attenuated ventilatory response to hypoxaemia at vecuronium-induced partial neuromuscular block. Acta Anaesthesiol. Scand., 1992, 36, p. 710-715. Go to original source... Go to PubMed...
  16. Eriksson, L. I., Sundman, E., Olsson, R. et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology, 1997, 87, p. 1029-1031. Go to original source... Go to PubMed...
  17. Kopman, A. F., Yee, P. S., Neuman, G. G. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology, 1997, 86, p. 765-771. Go to original source... Go to PubMed...
  18. Adamus, M., Marek, O. Monitorování účinku kurarimimetik během anestezie - současný stav v České republice. Anest. neodklad. Péče, 2000, 11, p. 245-250.
  19. Greer, R., Harper, N. J., Pearson, A. J. Neuromuscular monitoring by intensive care nurses: comparison of acceleromyography and tactile assessment. Br. J. Anaesth., 1998, 80, p. 384-385. Go to original source... Go to PubMed...
  20. Mortensen, C. R., Berg, H., El-Mahdy, A., Viby-Mogensen, J. Perioperative monitoring of neuromuscular transmission using acceleromyography prevents residual neuromuscular block following pancuronium. Acta Anaesthesiol. Scand., 1995, 39, p. 797-801. Go to original source... Go to PubMed...
  21. Bevan, D. Reversal of neuromuscular block: the case FOR reversal. Acta Anaesthesiol. Scand., Suppl, 1997, 41, p. 102. Go to original source... Go to PubMed...
  22. Hovorka, J., Korttila, K., Nelskyla, K., Soikkeli, A., Sarvela, J., Paatero, H., Halonen, P., Yli-Hankala, A. Reversal of neuromuscular blockade with neostigmine has no effect on the incidence or severity of postoperative nausea and vomiting. Anesth. Analg., 1997, 85, p. 1359-1361. Go to original source...
  23. Cheng, C. R., Sessler, D. I., Apfel, C. C. Does neostigmine administration produce a clinically important increase in postoperative nausea and vomiting? Anesth. Analg., 2005, 101, p. 1349-1355. Go to original source... Go to PubMed...
  24. Sorgenfrei, I. F., Viby-Mogensen, J., Swiatek, F. A. Does evidence lead to a change in clinical practice? Danish anaesthetists' and nurse anesthetists' clinical practice and knowledge of postoperative residual curarization. Ugeskrift for laeger, 2005, 167, p. 3878-3882. Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.